TI
SANA icon

Trexquant Investment’s Sana Biotechnology SANA Stock Holding History

Trexquant Investment’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,178
Closed -$165K – 1820
2024
Q2 		$165K Buy
+30,178
New +$240K ﹤0.01% 1452
2023
Q4 		– Sell
-136,426
Closed -$528K – 1737
2023
Q3 		$528K Buy
+136,426
New +$733K 0.01% 992
2022
Q4 		– Sell
-95,550
Closed -$573K – 1690
2022
Q3 		$573K Buy
+95,550
New +$690K 0.02% 757
2022
Q1 		– Sell
-14,553
Closed -$225K – 1675
2021
Q4 		$225K Buy
14,553
+2,883
+25% +$55.6K 0.01% 1087
2021
Q3 		$263K Buy
+11,670
New +$245K 0.02% 815

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Trexquant Investment's SANA Position: Q3 2024 in Review

Trexquant Investment sold out of Sana Biotechnology (SANA) in Q3 2024, closing a stake of 30,178 shares — an estimated $165K sold.

Trexquant Investment first reported a position in SANA in Q3 2021 and held it in 5 quarters. The position peaked at $573K in Q3 2022. 155 funds tracked by Wall St. Rank hold SANA as of Q3 2024.

  • Trexquant Investment reported no remaining Sana Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Trexquant Investment sold 30,178 Sana Biotechnology shares in Q3 2024, an estimated $165K.
  • Trexquant Investment first reported a position in Sana Biotechnology in Q3 2021 and held it in 5 quarters.
  • Trexquant Investment's Sana Biotechnology position peaked at $573K in Q3 2022.
  • 155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2024.

Based on Trexquant Investment's 13F filing for Q3 2024, filed 12 Nov 2024.